REN and cancer: Components of the RAS, i.e., renin, pro-renin receptor (PRR), angiotensin-converting enzyme (ACE), ACE2, angiotensin II receptor 1 (AT1R), and angiotensin II receptor 2 (AT2R), have been associated with the development of cancer [28,33].